MYCN and in situ carcinoma: This latter group included CyclinD2, an early marker of CIS and important for transformation of germ cell tumors [77,78], and Mycn, a proto-oncogene effector downstream of GNDF/GRFa1 favoring proliferation of SSCs [41].